Business
Medical Marijuana, Inc. Subsidiary Kannaway® Enters Strategic Partnership With Endocanna Health to Create and Sell Endocannabinoid DNA Test Products
Medical Marijuana, Inc. Subsidiary Kannaway® Enters Strategic Partnership With Endocanna Health to Create and Sell Endocannabinoid DNA Test Products.
About this update from Medical Marijuana, Inc.
[{"type":"text","content":"\n\n\n\nMedical Marijuana, Inc. Subsidiary Kannaway® Enters Strategic Partnership With Endocanna Health to Create and Sell Endocannabinoid DNA Test Products\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nMedical Marijuana, Inc. Subsidiary Kannaway® Enters Strategic Partnership With Endocanna Health to Create and Sell Endocannabinoid DNA Test Products\nPR Newswire\nSAN DIEGO, Aug. 1, 2019\n\n\n\nSAN DIEGO, Aug. 1, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) (the \"Company\"), the first publicly traded cannabis company in the United States that launched the world's preeminent cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has entered a strategic partnership with Endocanna Health, Inc., (\"Endocanna\") a research and development biotechnology company specializing in endocannabinioid DNA testing and personalization. \nKannaway® and Endocanna will collaborate on the development and distribution of endocannabinoid DNA test products. Under the terms of the agreement, Endocanna will manufacture its patent-pending Endocannabinoid DNA Test Kits (the \"Kits\") and license its proprietary DNA technology to Kannaway®. The Kits, designed to provide consumers with personalized data about how cannabidiol (CBD) and other cannabinoids may interact with their body's regulatory system, will be co-branded and sold exclusively through Kannaway®'s network of brand ambassadors. As part of the agreement, Kannaway® will have the opportunity to incorporate Endocanna's genetically-aligned formulations into Kannaway's products.\n\"Our goal, in addition to offering high-quality hemp-derived CBD products, is to provide our customers with education on which CBD products may work best for them,\" said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. \"This partnership creates an opportunity for us to do this in an initial hyper-personalized way and help consumers learn how to incorporate CBD into their everyday lives. We are very excited about our first steps in this endeavor with ...